Lumo Supplements
In Development

Next-Generation Performance Gummies. Built on Proven Science.

We are developing a high-quality creatine gummy for the Australian market, focused on performance, formulation integrity, and compliant execution.

This site is intended for ingredient and manufacturing partners. Consumer launch details will be published separately.

Brand-led development

Specification-driven formulation and documented sourcing pathways.

Australia-first

Built for Australian compliance and warm-climate distribution realities.

IP-respectful sourcing

Restricted ingredients only via official authorisation and traceable supply.

A Brand-Led Supplement Company

Lumo Supplements is an Australian-based brand in active product development. Our initial product is a creatine gummy designed for active adults with an interest in performance nutrition who value simplicity, consistency, and evidence-based formulation. As the brand owner, we maintain direct oversight of formulation discipline, ingredient sourcing, and manufacturing standards. We are finalising formulation architecture and ingredient sourcing ahead of pilot production.

Product Overview

Our creatine gummy is currently in active development. We are working through key engineering tradeoffs including dose accuracy, stability in warm climates, taste profile optimisation, and regulatory compliance. The goal is a product that delivers a meaningful creatine dose in a convenient, shelf-stable format that meets Australian dietary supplement requirements.

Primary active
Micronised creatine monohydrate
Target daily dose
5 g creatine per serve
Format
Pectin-based gummies
Intended market
Australia (initial)
Regulatory approach
FSANZ-aligned dietary supplement

Final serving format (number of gummies) is being validated through OEM feasibility testing.

Why We Are Exploring AstraGin®

Creatine monohydrate is well-validated on its own. We are exploring AstraGin® as an adjunct ingredient where it provides genuine benefit for nutrient uptake and consistency of absorption. Our interest is based on its clinically substantiated mechanism, safety profile, and alignment with premium formulation standards.

We are seeking technical guidance directly from the IP holder to ensure any inclusion is appropriate, compliant, and correctly implemented.

  • Seeking guidance on appropriate inclusion rates
  • Assessing compatibility within gummy matrices
  • Confirming authorised sourcing pathways into our OEM partner

We make no consumer-facing claims on this page.

Responsible Ingredient Sourcing

We recognise AstraGin® is patented and can only be sourced under official authorisation. We are seeking to engage directly with the IP holder, ensure compliant and traceable supply into our manufacturing partner, and use AstraGin® strictly within recommended parameters. We do not source restricted ingredients via grey-market channels.

Manufacturing & Quality

Pectin-based system

Selected for stability and warm-climate suitability.

Process controls

Temperature and moisture control targets defined with OEM.

Testing intent

Batch documentation and active ingredient verification planned.

Shelf stability

Target shelf life ~18 months under standard storage guidance (cool, dry, <25°C).

OEM partners are selected based on demonstrated experience with commercial, high-load functional gummies.

Final shelf life will be confirmed through stability testing and OEM documentation.

Current Development Status

Company formation and brand infrastructure

In progress

Formulation architecture defined

In progress

OEM feasibility discussions

In progress

Authorised ingredient partnership discussions

Starting now

Pilot batch planning

Next

Ingredient Partnership Enquiries

If you are the authorised supplier or representative for AstraGin®, we would welcome a discussion regarding authorisation requirements, technical guidance for gummy applications, and next steps for compliant supply into our manufacturing partner.

All enquiries are handled confidentially and used solely for partnership discussions.

Documentation Available on Request

  • Draft ingredient specification
  • Proposed inclusion ranges
  • Draft label (non-public)
  • Stability and testing plan
Built with v0